Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Tentamen (uitwerkingen)

WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS FINAL EXAM 2026/2027 | Comprehensive Study Guide | Verified Answers | Pass Guaranteed - A+ Graded

Beoordeling
-
Verkocht
-
Pagina's
37
Cijfer
A+
Geüpload op
28-05-2026
Geschreven in
2025/2026

Pass the WGU D027 Advanced Pathopharmacological Foundations Final Exam on your first attempt with this comprehensive study guide for 2026/2027 featuring verified answers. This A+ Graded resource is a complete comprehensive study guide with verified answers covering all advanced pathopharmacological domains tested on the WGU Final Exam. Cellular & Genetic Foundations: cellular adaptation (atrophy, hypertrophy, hyperplasia, metaplasia, dysplasia), cell injury and death (apoptosis, necrosis types including coagulative, liquefactive, caseous, fat, gangrenous), genetic disorders (chromosomal aneuploidy/trisomy/monosomy, single-gene autosomal dominant/recessive, X-linked, mitochondrial inheritance, multifactorial disorders, epigenetics). Inflammation & Immunity: acute vs chronic inflammation, vascular and cellular phases, chemical mediators (histamine, prostaglandins, leukotrienes, cytokines, complement system), wound healing (phases: hemostasis, inflammation, proliferation, remodeling; primary/secondary/tertiary intention), fever pathogenesis, hypersensitivity reactions (Type I anaphylactic, Type II cytotoxic, Type III immune complex, Type IV delayed cell-mediated), autoimmune disorders (SLE, rheumatoid arthritis, Hashimoto thyroiditis, Graves disease, type 1 diabetes, multiple sclerosis), immunodeficiency disorders (primary genetic vs secondary acquired including HIV/AIDS pathophysiology, CD4 count, opportunistic infections), transplant rejection (hyperacute, acute, chronic, graft-versus-host disease). Hemodynamics & Shock: edema mechanisms, hyperemia vs congestion, hemorrhage classifications, thrombosis (Virchow's triad: endothelial injury, hypercoagulability, stasis), embolism types (thromboembolism, fat, air, amniotic fluid, paradoxical), infarction (red vs white infarcts), shock pathophysiology (hypovolemic, cardiogenic, distributive/septic, neurogenic, anaphylactic), SIRS and MODS (systemic inflammatory response syndrome, multiple organ dysfunction syndrome), DIC (disseminated intravascular coagulation). Neoplasia & Oncology: carcinogenesis (initiation, promotion, progression), oncogenes and proto-oncogenes, tumor suppressor genes (p53, RB, BRCA1/2), hallmarks of cancer, benign vs malignant tumor characteristics, cancer staging (TNM classification: Tumor, Node, Metastasis), grading (histologic differentiation), metastasis pathways (lymphatic, hematogenous, seeding), paraneoplastic syndromes, tumor markers (PSA, CEA, CA-125, AFP, hCG, CA 19-9, HER2/neu), chemotherapy mechanisms, radiation therapy effects. Pharmacological Foundations: pharmacokinetics (absorption - bioavailability, first-pass effect; distribution - protein binding, volume of distribution, blood-brain barrier; metabolism - CYP450 enzyme system, phase I/II reactions, first-order vs zero-order kinetics; excretion - renal clearance, glomerular filtration, half-life, steady state), pharmacodynamics (receptor theory - agonists, partial agonists, antagonists, inverse agonists; dose-response curves - potency, efficacy, therapeutic index, therapeutic window; drug-receptor binding affinity, intrinsic activity; ED50, TD50, LD50), pharmacogenomics (CYP2D6, CYP2C19, CYP3A4/5, TPMT, VKORC1, HLA-B*5701, warfarin sensitivity, codeine metabolism, clopidogrel activation), adverse drug reactions (Type A augmented - predictable dose-dependent; Type B bizarre - idiosyncratic, allergic; Type C chronic; Type D delayed; Type E end-of-treatment; Type F failure), drug-drug and drug-food interactions (induction vs inhibition of CYP enzymes, grapefruit juice effect, warfarin-Vitamin K, MAOI-tyramine), medication safety across lifespan: pregnancy (FDA pregnancy categories A/B/C/D/X, teratogenesis), lactation (milk-to-plasma ratio, infant risk), pediatrics (organ immaturity, weight-based/kg dosing, body surface area, off-label use, Beers criteria for children), older adults (polypharmacy, altered pharmacokinetics (reduced renal/hepatic function, decreased protein binding, increased volume of distribution), pharmacodynamics changes, anticholinergic burden, Beers Criteria 2023, STOPP/START criteria). Integrated Systems Pathopharmacology: cardiovascular (hypertension, heart failure (HFrEF vs HFpEF), atherosclerosis, myocardial infarction, angina, dyslipidemia pharmacology - statins, beta-blockers, ACE inhibitors, ARBs, CCBs, diuretics, anticoagulants (warfarin, DOACs: apixaban, rivaroxaban, dabigatran), antiplatelets (aspirin, clopidogrel, ticagrelor)), respiratory (COPD, asthma, pneumonia, pulmonary embolism, pharmacology - bronchodilators (beta-agonists, anticholinergics), corticosteroids, leukotriene modifiers, mast cell stabilizers, methylxanthines), renal (acute kidney injury - prerenal/intrinsic/postrenal, chronic kidney disease stages 1-5, glomerulonephritis, pharmacology - diuretics (loop, thiazide, potassium-sparing, osmotic)), endocrine (diabetes mellitus Type 1 vs Type 2 pathophysiology, complications (retinopathy, nephropathy, neuropathy), pharmacology - insulin types (rapid/short/intermediate/long-acting), oral hypoglycemics (metformin, sulfonylureas, DPP-4 inhibitors, GLP-1 agonists, SGLT2 inhibitors, TZDs), thyroid disorders (hypothyroidism - Hashimoto, levothyroxine; hyperthyroidism - Graves, methimazole, PTU), adrenal disorders (Cushing's, Addison's), GI (GERD, PUD, IBD (Crohn's vs UC), cirrhosis, pharmacology - PPIs, H2 blockers, antacids, 5-ASA, immunomodulators), neurology (stroke - ischemic vs hemorrhagic, seizures, Parkinson's disease, Alzheimer's disease, multiple sclerosis, pharmacology - anti-epileptics, dopaminergic agents, cholinesterase inhibitors, NMDA antagonists), hematology (anemias (iron-deficiency, B12/folate deficiency, hemolytic, sickle cell, aplastic), coagulopathies (hemophilia, von Willebrand, thrombophilia), leukemia/lymphoma classifications). Comprehensive Case Studies: integrated patient cases requiring application of pathophysiological principles, pharmacological decision-making, and clinical reasoning across complex, multi-system scenarios. Each answer includes detailed clinical, pathophysiological, and pharmacological rationales. Perfect for MSN, NP, and advanced practice nursing students preparing for the comprehensive WGU D027 final exam. With our Pass Guarantee, you can confidently pass your WGU D027 Final Exam. Download your complete WGU D027 Advanced Pathopharmacological Foundations Final Exam Comprehensive Study Guide instantly!

Meer zien Lees minder
Instelling
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS
Vak
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS

Voorbeeld van de inhoud

WGU D027 ADVANCED PATHOPHARMACOLOGICAL
FOUNDATIONS FINAL EXAM 2026/2027 | Comprehensive
Study Guide | Verified Answers | Pass Guaranteed - A+
Graded

Section 1: Cellular & Molecular Pathophysiology (Q1-12)

Q1. A patient presents with acute myocardial infarction. The cardiologist explains that
prolonged ischemia has caused irreversible cell injury. Which cellular change is most
characteristic of irreversible hypoxic injury?

A. Cellular swelling with intact plasma membrane
B. Karyolysis and release of cellular enzymes into the extracellular space
C. Decreased intracellular calcium concentration
D. Preservation of mitochondrial structure

Correct Answer: B. Karyolysis and release of cellular enzymes into the extracellular
space [CORRECT]
Rationale: Irreversible hypoxic injury is characterized by nuclear changes (karyolysis,
pyknosis, karyorrhexis) and plasma membrane disruption leading to enzyme leakage.
Options A, C, and D describe reversible injury or incorrect ion shifts.

Q2. A 45-year-old male with chronic alcohol use develops hepatic steatosis. Which
mechanism best explains the accumulation of fat in hepatocytes?

A. Increased beta-oxidation of fatty acids
B. Decreased synthesis of apolipoproteins impairing VLDL export
C. Increased HDL-mediated cholesterol clearance
D. Enhanced mitochondrial ATP production

Correct Answer: B. Decreased synthesis of apolipoproteins impairing VLDL export
[CORRECT]

,Rationale: Alcohol metabolism impairs apolipoprotein synthesis, reducing VLDL
assembly and export from hepatocytes, leading to triglyceride accumulation. Options A,
C, and D describe mechanisms that would reduce, not cause, steatosis.

Q3. A patient with Huntington disease has a CAG trinucleotide repeat expansion in the
HTT gene. Which type of genetic mutation is this?

A. Point mutation
B. Frameshift mutation
C. Dynamic mutation with anticipation
D. Silent mutation

Correct Answer: C. Dynamic mutation with anticipation [CORRECT]
Rationale: Trinucleotide repeat expansions are dynamic mutations that can expand
during gametogenesis, causing earlier onset and more severe disease in successive
generations (anticipation). This is not a point, frameshift, or silent mutation.

Q4. A tumor suppressor gene undergoes hypermethylation of its promoter region.
Which epigenetic consequence occurs?

A. Increased transcription of the gene
B. Gene silencing without alteration of the DNA sequence
C. Activation of oncogenic pathways
D. Increased histone acetylation

Correct Answer: B. Gene silencing without alteration of the DNA sequence [CORRECT]
Rationale: Promoter hypermethylation is an epigenetic modification that silences gene
transcription without changing the DNA sequence. Tumor suppressor silencing
contributes to carcinogenesis. Options A, C, and D describe opposite or unrelated
mechanisms.

,Q5. A cell exposed to radiation undergoes programmed cell death with cell shrinkage,
chromatin condensation, and formation of apoptotic bodies. Which pathway is primarily
activated?

A. Necrosis with ATP depletion
B. Intrinsic (mitochondrial) apoptosis pathway
C. Pyroptosis with IL-1β release
D. Ferroptosis with iron-dependent lipid peroxidation

Correct Answer: B. Intrinsic (mitochondrial) apoptosis pathway [CORRECT]
Rationale: Radiation-induced DNA damage activates the intrinsic apoptosis pathway via
p53, Bax/Bak, cytochrome c release, and caspase activation. The described morphology
(shrinkage, condensation, apoptotic bodies) is classic apoptosis, not necrosis,
pyroptosis, or ferroptosis.

Q6. A patient with cystic fibrosis has a deletion of phenylalanine at position 508
(ΔF508) in the CFTR protein. Which mutation type is this?

A. Nonsense mutation
B. Missense mutation
C. Deletion mutation affecting protein folding
D. Splice site mutation

Correct Answer: C. Deletion mutation affecting protein folding [CORRECT]
Rationale: The ΔF508 mutation is a three-nucleotide deletion causing loss of a
phenylalanine residue, leading to defective CFTR protein folding and premature
degradation. It is not a nonsense, missense, or splice site mutation.

Q7. Oxidative stress causes cellular injury primarily through:

A. Generation of reactive oxygen species (ROS) that damage lipids, proteins, and DNA
B. Increased synthesis of antioxidant enzymes
C. Enhanced mitochondrial membrane potential
D. Decreased calcium influx

, Correct Answer: A. Generation of reactive oxygen species (ROS) that damage lipids,
proteins, and DNA [CORRECT]
Rationale: ROS including superoxide, hydrogen peroxide, and hydroxyl radicals cause
lipid peroxidation, protein oxidation, and DNA strand breaks. Options B, C, and D
describe protective or incorrect mechanisms.

Q8. A signal transduction pathway involves G-protein activation of adenylyl cyclase,
increasing cAMP and activating protein kinase A. Which receptor type initiates this
cascade?

A. Receptor tyrosine kinase
B. G-protein coupled receptor (GPCR)
C. Nuclear hormone receptor
D. Ligand-gated ion channel

Correct Answer: B. G-protein coupled receptor (GPCR) [CORRECT]
Rationale: GPCRs coupled to Gs proteins activate adenylyl cyclase, increasing cAMP
and PKA activity. This is the classic mechanism for β-adrenergic receptors. Receptor
tyrosine kinases, nuclear receptors, and ion channels use different signaling
mechanisms.

Q9. A patient with chronic granulomatous disease has defective NADPH oxidase. Which
cellular function is impaired?

A. Phagosome-lysosome fusion
B. Generation of microbicidal reactive oxygen species in phagocytes
C. Antibody production by B cells
D. T-cell receptor signaling

Correct Answer: B. Generation of microbicidal reactive oxygen species in phagocytes
[CORRECT]
Rationale: NADPH oxidase generates superoxide (respiratory burst) for microbial killing.
Deficiency causes recurrent infections with catalase-positive organisms. Options A, C,
and D describe unrelated immune functions.

Geschreven voor

Instelling
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS
Vak
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS

Documentinformatie

Geüpload op
28 mei 2026
Aantal pagina's
37
Geschreven in
2025/2026
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

$16.50
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF


Ook beschikbaar in voordeelbundel

Maak kennis met de verkoper

Seller avatar
De reputatie van een verkoper is gebaseerd op het aantal documenten dat iemand tegen betaling verkocht heeft en de beoordelingen die voor die items ontvangen zijn. Er zijn drie niveau’s te onderscheiden: brons, zilver en goud. Hoe beter de reputatie, hoe meer de kwaliteit van zijn of haar werk te vertrouwen is.
NURSEGEDSTUDYGUIDE Chamberlain College Of Nursing
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
490
Lid sinds
3 jaar
Aantal volgers
254
Documenten
4680
Laatst verkocht
1 dag geleden
Writing and Academics (berhtonehorace at gmail dot com)

I offer a full range of online academic services aimed to students who need support with their academics. Whether you need tutoring, help with homework, paper writing, or proofreading, I am here to help you reach your academic goals. My experience spans a wide range of disciplines. I provide online sessions using the Google Workplace. If you have an interest in working with me, please contact me for a free consultation to explore your requirements and how I can help you in your academic path. I am pleased to help you achieve in your academics and attain your full potential.

Lees meer Lees minder
3.8

101 beoordelingen

5
50
4
15
3
14
2
6
1
16

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen